報告摘要

The global Repurposed Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Repurposed Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Repurposed Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Repurposed Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Repurposed Drugs include Teva, Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, R-Pharma, Glenmark and Fujifilm, among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Repurposed Drugs market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Repurposed Drugs. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Repurposed Drugs Market by Company Teva Johnson & Johnson Novartis Mylan Pfizer GSK R-Pharma Glenmark Fujifilm Dr. Reddy ChemRar Group Bausch Health Repurposed Drugs Segment by Type Generic Drugs Clinical Trial Failed Drugs Repurposed Drugs Segment by Application Cardiovascular Diseases Mental Illness Cancer Other Repurposed Drugs Segment by Region North America United States Canada Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Repurposed Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Repurposed Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Repurposed Drugs. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Repurposed Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Repurposed Drugs by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 Generic Drugs 2.2.3 Clinical Trial Failed Drugs 2.3 Repurposed Drugs by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Cardiovascular Diseases 2.3.3 Mental Illness 2.3.4 Cancer 2.3.5 Other 2.4 Assumptions and Limitations 3 Repurposed Drugs Breakdown Data by Type 3.1 Global Repurposed Drugs Historic Market Size by Type (2021-2026) 3.2 Global Repurposed Drugs Forecasted Market Size by Type (2027-2032) 4 Repurposed Drugs Breakdown Data by Application 4.1 Global Repurposed Drugs Historic Market Size by Application (2021-2026) 4.2 Global Repurposed Drugs Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global Repurposed Drugs Market Perspective (2021-2032) 5.2 Global Repurposed Drugs Growth Trends by Region 5.2.1 Global Repurposed Drugs Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 Repurposed Drugs Historic Market Size by Region (2021-2026) 5.2.3 Repurposed Drugs Forecasted Market Size by Region (2027-2032) 5.3 Repurposed Drugs Market Dynamics 5.3.1 Repurposed Drugs Industry Trends 5.3.2 Repurposed Drugs Market Drivers 5.3.3 Repurposed Drugs Market Challenges 5.3.4 Repurposed Drugs Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Repurposed Drugs Players by Revenue 6.1.1 Global Top Repurposed Drugs Players by Revenue (2021-2026) 6.1.2 Global Repurposed Drugs Revenue Market Share by Players (2021-2026) 6.2 Global Repurposed Drugs Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of Repurposed Drugs Head Office and Area Served 6.4 Global Repurposed Drugs Players, Product Type & Application 6.5 Global Repurposed Drugs Manufacturers Established Date 6.6 Global Repurposed Drugs Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Repurposed Drugs Market Size (2021-2032) 7.2 North America Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America Repurposed Drugs Market Size by Country (2021-2026) 7.4 North America Repurposed Drugs Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe Repurposed Drugs Market Size (2021-2032) 8.2 Europe Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe Repurposed Drugs Market Size by Country (2021-2026) 8.4 Europe Repurposed Drugs Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Repurposed Drugs Market Size (2021-2032) 9.2 Asia-Pacific Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific Repurposed Drugs Market Size by Country (2021-2026) 9.4 Asia-Pacific Repurposed Drugs Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America Repurposed Drugs Market Size (2021-2032) 10.2 South America Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America Repurposed Drugs Market Size by Country (2021-2026) 10.4 South America Repurposed Drugs Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa Repurposed Drugs Market Size (2021-2032) 11.2 Middle East & Africa Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa Repurposed Drugs Market Size by Country (2021-2026) 11.4 Middle East & Africa Repurposed Drugs Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Teva 12.1.1 Teva Company Information 12.1.2 Teva Business Overview 12.1.3 Teva Revenue in Repurposed Drugs Business (2021-2026) 12.1.4 Teva Repurposed Drugs Product Portfolio 12.1.5 Teva Recent Developments 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Company Information 12.2.2 Johnson & Johnson Business Overview 12.2.3 Johnson & Johnson Revenue in Repurposed Drugs Business (2021-2026) 12.2.4 Johnson & Johnson Repurposed Drugs Product Portfolio 12.2.5 Johnson & Johnson Recent Developments 12.3 Novartis 12.3.1 Novartis Company Information 12.3.2 Novartis Business Overview 12.3.3 Novartis Revenue in Repurposed Drugs Business (2021-2026) 12.3.4 Novartis Repurposed Drugs Product Portfolio 12.3.5 Novartis Recent Developments 12.4 Mylan 12.4.1 Mylan Company Information 12.4.2 Mylan Business Overview 12.4.3 Mylan Revenue in Repurposed Drugs Business (2021-2026) 12.4.4 Mylan Repurposed Drugs Product Portfolio 12.4.5 Mylan Recent Developments 12.5 Pfizer 12.5.1 Pfizer Company Information 12.5.2 Pfizer Business Overview 12.5.3 Pfizer Revenue in Repurposed Drugs Business (2021-2026) 12.5.4 Pfizer Repurposed Drugs Product Portfolio 12.5.5 Pfizer Recent Developments 12.6 GSK 12.6.1 GSK Company Information 12.6.2 GSK Business Overview 12.6.3 GSK Revenue in Repurposed Drugs Business (2021-2026) 12.6.4 GSK Repurposed Drugs Product Portfolio 12.6.5 GSK Recent Developments 12.7 R-Pharma 12.7.1 R-Pharma Company Information 12.7.2 R-Pharma Business Overview 12.7.3 R-Pharma Revenue in Repurposed Drugs Business (2021-2026) 12.7.4 R-Pharma Repurposed Drugs Product Portfolio 12.7.5 R-Pharma Recent Developments 12.8 Glenmark 12.8.1 Glenmark Company Information 12.8.2 Glenmark Business Overview 12.8.3 Glenmark Revenue in Repurposed Drugs Business (2021-2026) 12.8.4 Glenmark Repurposed Drugs Product Portfolio 12.8.5 Glenmark Recent Developments 12.9 Fujifilm 12.9.1 Fujifilm Company Information 12.9.2 Fujifilm Business Overview 12.9.3 Fujifilm Revenue in Repurposed Drugs Business (2021-2026) 12.9.4 Fujifilm Repurposed Drugs Product Portfolio 12.9.5 Fujifilm Recent Developments 12.10 Dr. Reddy 12.10.1 Dr. Reddy Company Information 12.10.2 Dr. Reddy Business Overview 12.10.3 Dr. Reddy Revenue in Repurposed Drugs Business (2021-2026) 12.10.4 Dr. Reddy Repurposed Drugs Product Portfolio 12.10.5 Dr. Reddy Recent Developments 12.11 ChemRar Group 12.11.1 ChemRar Group Company Information 12.11.2 ChemRar Group Business Overview 12.11.3 ChemRar Group Revenue in Repurposed Drugs Business (2021-2026) 12.11.4 ChemRar Group Repurposed Drugs Product Portfolio 12.11.5 ChemRar Group Recent Developments 12.12 Bausch Health 12.12.1 Bausch Health Company Information 12.12.2 Bausch Health Business Overview 12.12.3 Bausch Health Revenue in Repurposed Drugs Business (2021-2026) 12.12.4 Bausch Health Repurposed Drugs Product Portfolio 12.12.5 Bausch Health Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Repurposed Drugs Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Repurposed Drugs Revenue Market Share by Type (2021-2026) Table 7. Global Repurposed Drugs Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Repurposed Drugs Revenue Market Share by Type (2027-2032) Table 9. Global Repurposed Drugs Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Repurposed Drugs Revenue Market Share by Application (2021-2026) Table 11. Global Repurposed Drugs Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Repurposed Drugs Revenue Market Share by Application (2027-2032) Table 13. Global Repurposed Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Repurposed Drugs Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Repurposed Drugs Market Share by Region (2021-2026) Table 16. Global Repurposed Drugs Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Repurposed Drugs Market Share by Region (2027-2032) Table 18. Repurposed Drugs Industry Trends Table 19. Repurposed Drugs Industry Drivers Table 20. Repurposed Drugs Industry Opportunities and Challenges Table 21. Repurposed Drugs Market Restraints Table 22. Global Top Repurposed Drugs Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Repurposed Drugs Revenue Market Share by Players (2021-2026) Table 24. Global Repurposed Drugs Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Repurposed Drugs, Headquarters and Area Served Table 26. Global Repurposed Drugs Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Repurposed Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Repurposed Drugs Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Repurposed Drugs Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Repurposed Drugs Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Repurposed Drugs Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Repurposed Drugs Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Repurposed Drugs Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Repurposed Drugs Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Repurposed Drugs Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Repurposed Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Repurposed Drugs Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Repurposed Drugs Market Size by Country (2027-2032) & (US$ Million) Table 45. Teva Company Information Table 46. Teva Business Overview Table 47. Teva Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 48. Teva Repurposed Drugs Product Portfolio Table 49. Teva Recent Developments Table 50. Johnson & Johnson Company Information Table 51. Johnson & Johnson Business Overview Table 52. Johnson & Johnson Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 53. Johnson & Johnson Repurposed Drugs Product Portfolio Table 54. Johnson & Johnson Recent Developments Table 55. Novartis Company Information Table 56. Novartis Business Overview Table 57. Novartis Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 58. Novartis Repurposed Drugs Product Portfolio Table 59. Novartis Recent Developments Table 60. Mylan Company Information Table 61. Mylan Business Overview Table 62. Mylan Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 63. Mylan Repurposed Drugs Product Portfolio Table 64. Mylan Recent Developments Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 68. Pfizer Repurposed Drugs Product Portfolio Table 69. Pfizer Recent Developments Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 73. GSK Repurposed Drugs Product Portfolio Table 74. GSK Recent Developments Table 75. R-Pharma Company Information Table 76. R-Pharma Business Overview Table 77. R-Pharma Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 78. R-Pharma Repurposed Drugs Product Portfolio Table 79. R-Pharma Recent Developments Table 80. Glenmark Company Information Table 81. Glenmark Business Overview Table 82. Glenmark Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 83. Glenmark Repurposed Drugs Product Portfolio Table 84. Glenmark Recent Developments Table 85. Fujifilm Company Information Table 86. Fujifilm Business Overview Table 87. Fujifilm Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 88. Fujifilm Repurposed Drugs Product Portfolio Table 89. Fujifilm Recent Developments Table 90. Dr. Reddy Company Information Table 91. Dr. Reddy Business Overview Table 92. Dr. Reddy Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 93. Dr. Reddy Repurposed Drugs Product Portfolio Table 94. Dr. Reddy Recent Developments Table 95. ChemRar Group Company Information Table 96. ChemRar Group Business Overview Table 97. ChemRar Group Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 98. ChemRar Group Repurposed Drugs Product Portfolio Table 99. ChemRar Group Recent Developments Table 100. Bausch Health Company Information Table 101. Bausch Health Business Overview Table 102. Bausch Health Revenue in Repurposed Drugs Business (2021-2026) & (US$ Million) Table 103. Bausch Health Repurposed Drugs Product Portfolio Table 104. Bausch Health Recent Developments Table 105. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Repurposed Drugs Product Image Figure 5. Global Repurposed Drugs Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Repurposed Drugs Market Share by Type: 2025 VS 2032 Figure 7. Generic Drugs Product Figure 8. Clinical Trial Failed Drugs Product Figure 9. Global Repurposed Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Repurposed Drugs Market Share by Application: 2025 VS 2032 Figure 11. Cardiovascular Diseases Product Figure 12. Mental Illness Product Figure 13. Cancer Product Figure 14. Other Product Figure 15. Global Repurposed Drugs Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Repurposed Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Repurposed Drugs Market Share by Region: 2025 VS 2032 Figure 18. Global Repurposed Drugs Market Share by Players in 2025 Figure 19. Global Repurposed Drugs Manufacturers Established Date Figure 20. Global Top 5 and 10 Repurposed Drugs Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Repurposed Drugs Market Share by Country (2021-2032) Figure 24. United States Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Repurposed Drugs Market Share by Country (2021-2032) Figure 27. Europe Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Repurposed Drugs Market Share by Country (2021-2032) Figure 29. Germany Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Repurposed Drugs Market Share by Country (2021-2032) Figure 39. China Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Repurposed Drugs Market Share by Country (2021-2032) Figure 44. Australia Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Repurposed Drugs Market Share by Country (2021-2032) Figure 49. Brazil Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Repurposed Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Teva Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 55. Johnson & Johnson Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 56. Novartis Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 57. Mylan Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 58. Pfizer Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 59. GSK Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 60. R-Pharma Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 61. Glenmark Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 62. Fujifilm Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 63. Dr. Reddy Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 64. ChemRar Group Revenue Growth Rate in Repurposed Drugs Business (2021-2026) Figure 65. Bausch Health Revenue Growth Rate in Repurposed Drugs Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Repurposed Drugs Industry Research Report 2026

授權報價

報告摘要

提及公司